|
| |
Image Results
Loading...
Loading...
Celgene September 2009 Pages on BioPortfolio:
BioPortfolio - Celgene Corporation
11th September, 2009, Analytical Research and Development, Celgene Corporation, Summit, NJ, J Chromatogr A. 2009 Apr 10;1216(15):3328-36. Epub 2009 Feb 21. ...
http://www.bioportfolio.com/biocorporate/466-Celgene+Corpora...
|
Biotechnology News primecap. fedex. 009. guru. vanguard. numvis ...
22 Nov 2009 ... Gummy Bears nutritional supplements for children in September 2009 and its.. . International Business Times: Nov 18 2009 9:34PM ... BiomedReports: News and
FDA Updates for Celgene (NASDAQ:CELG), Genzyme (Nasdaq:GENZ) ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Celgene Corporation - Profile
Static headspace gas chromatography (HS-GC) with immiscible binary...11th September, 2009. Analytical Research and Development, Celgene Corporation,
Summit, ...
http://www.bioportfolio.com/biocorporate/466-Celgene+Corpora...
|
|
Biotechnology News VELCADE Search
will be hosting an Investor/Analyst Day on Tuesday, September 22nd in New York ... Analyst raises Celgene rating to 'Outperform,' expecting greater use of ...
http://www.bioportfolio.co.uk/VELCADE-news.htm...
|
BioTech Sage Report - ReCap on BioGen, Celgene, ICOS, Genzyme, Imclone
Friday October 16 2009 | Biotechnology feed | All feeds ... The usual trend for the biotech sector is a rally in August that carries over to September. ...
Second, Celgene announced that the company would acquire Anthrogenesis for $45
...
http://www.bioportfolio.com/news/biotechsage_1.htm...
|
BioPortfolio - AOF2 - amine oxidase (flavin containing) domain 2
8th October, 2009, Celgene, San Diego, California 92121, USA. ... 24th September , 2009, Department of Biochemistry and Molecular Biology, Peking University ...
http://www.bioportfolio.com/gene/23028-AOF2.html...
|
BiotechTracker: Thalidomide Plus Temozolmide for Melanoma
Friday November 20 2009 | Biotechnology feed | All feeds ... September 08, 2003 Celgene's (NASDAQ: CELG) Thalomid (thalidomide), in combination with low ...
http://www.bioportfolio.com/news/biotracker_180.htm...
|
BioPortfolio - Genzyme - Profile
PURPOSE:: To evaluate life expectancy and cause of death among patients...12th September, 2009 ... News and FDA Updates for Celgene (NASDAQ:CELG), Genzyme (
Nasdaq:GENZ). American Chronicle: Nov 16 2009 12:51AM Matching: genzyme ...
http://www.bioportfolio.com/biocorporate/537-Genzyme.pdf...
|
BioPortfolio - Swiss 3t3 Cells - InDepth
Celgene, San Diego, CA 92121, USA.- Blood. 2009 Jul 9;114(2):338-45. ... Sprouty2 (Spry2) is a key regulator of the receptor tyrosine...30th September,
2008 ...
http://www.bioportfolio.com/indepth/Swiss_3t3_Cells.pdf...
|
BioPortfolio - Arthritis Psoriatic - InDepth
BACKGROUND: Current research has confirmed that many inflammatory...24th September, 2009 ... GenomeWeb: Nov 13 2009 2:14AM Matching: arthritis psoriatic
... Celgene Says Psoriatic Arthritis Drug Demonstrated Sustained Response At Six
...
http://www.bioportfolio.com/indepth/Arthritis_Psoriatic.pdf...
| Results from other life science and pharmaceutical sites:
Summary of CELGENE CORP /DE/ - Yahoo! Finance
30 Oct 2009 ... Celgene Corporation and its subsidiaries (collectively "we" or "our") is a ... Three-Month Periods Ended September 30, 2009 and 2008 Total ...
http://biz.yahoo.com/e/091030/celg10-q.html...
|
Celgene Corporation to Present at the UBS Global Life Sciences ...
9/17/2009. SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today ... September 22, 2009 at 1:30 p.m. ET will be webcast live and will be
...
http://www.biospace.com/news_story.aspx?NewsEntityId=156323...
|
Thalidomide - Wikipedia, the free encyclopedia
In 2005, Celgene received FDA approval for lenalidomide (Revlimid) as the ... Foggo, Daniel (13 September 2009). "Thalidomide victim Gary Syner to go on ...
http://en.wikipedia.org/wiki/Thalidomide...
|
Ligand Collaborations
Pfizer received approval in March 2009 from the European Commission (EC) for ... I clinical trials in September 2007 and a BACE inhibitor for Alzheimer's disease
for ... The research phase of the collaboration is complete and Celgene is ...
http://www.pharmacopeia.com/collaborations.php...
|
Anthony M. Insogna
"Top 25 IP Portfolio Managers in California," Daily Journal 2009; voted by ... Celgene files patent suit against KV Pharmaceuticals over generic ...
Biotechnology Markets, Henry. Stewart Conference Studies. September 28, ...
http://www.jonesday.com/abc.aspx?url=/lawyers%2Fbio_pdf.aspx...
|
Expanded safety experience with lenalidomide plus dexamethasone in ...
Received February 4, 2009; Accepted April 15, 2009. ... Lenalidomide (Revlimid®; Celgene Corporation, Summit, NJ, USA) is a more potent analogue of thalidomide
that is ... Patients were enrolled in the study starting September 2005. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728892/...
|
GPC Biotech Reports Financial Results for Second Quarter and First ...
... for satraplatin with Celgene Corporation effective September 2008. ... Quarter over quarter results: second quarter 2009 compared to first quarter 2009
...
http://www.agennix.com/index.php?option=com_content&view=art...
|
Lenalidomide in combination with dexamethasone at first relapse in ...
Accepted March 9, 2009. Re-use of this article is permitted in accordance .... trials were initiated on 27 February 2003, and 22 September 2003, respectively.
.... This work was fully supported by Celgene Corporation, and the study was ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704925/...
|
Clinical Pharmacology & Therapeutics - Abstract of article ...
Correspondence: Steve D. Thomas, PhD, Celgene Corporation, 7 Powder Horn Drive, ... *Supported by the Celgene Corporation (Warren, NJ). Received 3 September
1998; ... 2009 American Society for Clinical Pharmacology and Therapeutics ...
http://www.nature.com/clpt/journal/v65/n5/abs/clpt1999393a.h...
|
Valuation of transfusion-free living in MDS: results of health ...
Published online 2009 September 8. doi: 10.1186/1477-7525-7-81. ... Org; Robert Knight: rknight/at/celgene.com; Michael Lübbert: Not/at/valid.com; ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746210/...
|
|
